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A year and a half ago, a young couple in their mid-thirties came to me as a
bioethicist, seeking advice conceming the morality of various fertilization
procedures. Judy and Ray had been trying to conceive for three years with
little success. After going through fertility testing it was determined that
one of Judy ' s fallopian tubes was blocked and inoperable, but the other
seemed functional. As a result, the fertility specialist prescribed clomid,
which is a fertility medication . Ten months later Judy was pregnant. In the
fourth week of her pregnancy it was determined that she had a tubal ectopic
pregnancy. The embryo was implanted in her left fallopian tube and this
presented a life-threatening situation due to the potential for hemorrhage.
Her obstetrician presented her with the four current procedures for the
management of tubal pregnancies. The first is expectant management,
wherein the woman is closely monitored but there is no direct action . The
reason for this is that statistics show that half of tubal pregnancies
spontaneously resolve themselves. I The second, salpingectomy, involves a
full or partial surgical procedure : wherein in the full procedure the entire
fallopian tube containing the embryo is surgically removed, and the severed
ends of the tube are brought together and sutured.
The third,
salpingostomy, involves making a linear incision , 2 cm in length or less, on
the anti mesenteric border immediately over the ectopic pregnancy. The
embryo usually will extrude from the incision and can be carefully
removed.
Fourth, methotrexate treatment (MTX), the drug MTX ,
administered systemically or injected at the site, inhibits DNA synthesis so

February, 2000

7

that the otherwise normal implantation enzymatic activity ceases? Judy ' s
obstetrician recommended the non-surgical solution of MTX treatment,
because it is the least medically invasive, the injection is given as an
outpatient, and it eliminates the costs and the medical risks of
hospitalization and surgery.3 The qut:stion presented to me as a bioethicist
was whether MTX treatment was morally justifiable by the Catholic
Church?
Various factors have to be considered regarding this case. First, Judy
is having numerous problems getting pregnant and after exploratory
surgery it appears that her right fallopian tube is nonfunctioning. MTX
treatment would preserve her functi oning fallopian tube and allow for the
possibility of future pregnancies. Second, Judy and Ray very much want to
have children, but if they opt for full or partial salpingectomy, which the
Church morally allows, they would never have their own biological
children. Their chances for adoption are slim because of their financial
status and their age. Third, prior to 1994, the Ethical and Religious
Directives for Catholic Health Care Facilities were very specific about the
procedures which were permitted in the management of a tubal pregnancy.
Any procedure which removes the embryo from the ectopic site is
prohibited. In the 1971 directives, specific procedures did not conform to
the moral law.4 In the revised 1994 edition nothing is stated about
particular procedures which are licit. Directive 48 of the revised Ethical
and Religious Directives states: " In case of extrauterine pregnancy, no
intervention is morally licit which constitutes a direct abortion."s The
Bishops no longer teach that specific procedures do not conform to the
moral law. Instead, they emphasize the basic principle that any procedure,
to be licit, must conform to the moral law regarding abortions. 6 There are a
number of ethical questions surrounding this issue, but the focus is on the
ethical ambiguity pertaining to whether MTX is a form of direct or indirect
abortion.
The purpose of this article is threefold: first, to examine the medical
reality of a tubal pregnancy and the function of MTX as a viable medical
treatment; second, to examine the ethical arguments for and against the use
of MTX as a viable option in the case: of a tubal pregnancy; third, to give an
ethical analysis of these arguments to determine if MTX is morally
justifiable in the case ofa tubal pregnancy.

Tubal Pregnancy and Methotrexate
An ectopic pregnancy is one in which implantation occurs outside the
endometrium and the endometrial cavity, such as in the cervix, uterine tube,
ovary, or the abdominal or pelvic cavity. It continues to . be the leading
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cause of maternal morbidity and a major reason for reduced child-bearing
potential among women of reproductive age. It is also the leading cause of
pregnancy-related deaths during the first trimester of pregnancy.
Approximately 95% of ectopic pregnancies occur in the fallopian tube.
The rate of occurrence of ectopic pregnancy increased from 4.5 to 16.8 per
1,000 pregnancies between 1970 and 1987.7 In 1995, the Centers for
Disease Control and Prevention (CDC) estimated a rate of 19.7 ectopic
pregnancies per 1,000 reported pregnancies. The CDC also reported that
ectopic pregnancy-related deaths made up 9% of all maternal deaths and
most of these deaths were due to tubal rupture. 8 The destruction of the
normal tubal anatomy remains the major cause of ectopic pregnancy and is
the explanation in about 50% of the cases. The histologic changes
associated with pelvic inflammatory disease (PID) are found in about half
of the tubes removed for an ectopic pregnancy. Other important risk
factors include a previous operation for an ectopic pregnancy, previous
tubal ligation, and conservative tubal procedures for the treatment of
infertility. Related to PID are other risks such as age and ethnicity.9
Although the use of oral contraceptives reduces the risk of ectopic
pregnancy by about 90%, the use of an intrauterine device may increase the
risk, in that when pregnancy does occur, «2%), about 4% to I 7% will be
an ectopic. The other occurrences of an ectopic pregnancy are probably a
result of hormonal imbalance, aberrations in tubal mortality, and
abnormalities in the embryo, including transmigration to the opposite tube
lo
and genetic abnormalities.
Diagnosis of an ectopic pregnancy is as unpredictable as the ectopic
pregnancy itself. Many times the patient may not become symptomatic
until rupture occurs. Approximately 70% of those patients not diagnosed
early present with the classic triad of symptoms, consisting of amenorrhea,
abdominal pain and abdominal vaginal bleeding. Initial signs of an ectopic
pregnancy are cramping pain and spotting shortly after the first missed
menstrual period. Gradual hemorrhage from the fallopian tube causes pain
and pressure, but rapid hemorrhage results in hypotension and shock.
Usually, uterine bleeding precedes these events as human chorionic
gonadotropin (hCG) levels decrease. I I Physical examination shows signs
of hemorrhage, shock, and lower abdominal peritoneal irritation that may
be lateralized. Pelvic examination will show the uterus to be enlarged, the
cervix to be tender to motion , and a tender mass may be palpated in one
adnexum. The cul-de-sac may bulge. Pain is often experienced in the
pelvis or abdomen , and usually occurs approximately in the fourth to sixth
week of gestation. Rupture and intraperitoneal bleeding occurs at six to ten
12
weeks. Abdominal and pelvic tenderness is the most consistent sign .
Either transcervical or abdominal ultrasonography can assist in diagnosis,
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and a laparoscopy can also be helpful.
Advancements in medical
technology and diagnostic techniqu(:s have allowed the discovery of an
ectopic pregnancy before rupture to have risen from one in every 136
deliveries to one in every 79 in the last ten years. 13
The prognosis for an ectopic pregnancy has been guarded.
Approximately one-third of the patients became infertile, one-third had
subsequent pregnancy loss (miscarriage or repeat ectopic), and one-third
had a full-term intrauterine pregnancy. However, with conservative
surgical treatment and nonsurgical treatments, viable pregnancy rates of
50% to 85% have been reported . Rt:sults are better if the oviduct has not
ruptured, emphasizing the importance of early diagnosis. This early
diagnosis is made possible by the use of vag inal ultrasound and serum
14
quantitative beta-hCG (human chorionic gonadotropin) determinations.
Biologically, in a normal uterine implantation, by the fifth day after
fertilization , the conceptus enters the blastocyst stage (preimplantation
embryo) of development. The bla5,tocyst has arrived in the uterus and
implantation usually occurs in the front or back wall of the endometrial
cavity near the fundus . At the blastol~yst stage the embryo has divided into
two major portions, the inner cell mass called the cytoblast, which will
develop into the fetus, and the outer cell mass called the trophoblast
(temporary structure), which gives rise to the placenta that attaches the
conceptus to the uterine wall and nourishes the embryo. In a tubal
implantation, the trophoblast attache5 itself to the wall of the fallopian tube.
The trophoblast cells secrete protein-digesting enzymes which enable the
blastocyst to secure itself to the mu(:osal layer of the fallopian tube. It is
the trophoblast, not the cytoblast, that causes the life-threatening pathology.
Due to the small size of the fallopian tube, the embryo will be unable to
develop and the mother's life will b,e threatened because of the inevitable
rupture and hemorrhaging of the tube . l As stated earlier, the four current procedures to treat a tubal
pregnancy are expectant managem en t, salpingectomy (full or partial),
salpingostomy, and MTX treatment. The Catholic C hurch allows for
expectant management and a full or partial salpingectomy because neither
would constitute a direct abortion . The salpingectomy would be an indirect
abortion by the principle of double effect. The direct intention in a
salpingectomy is to remove a pathological organ and a foreseen but
unintended consequence is that the nonviable embryo is terminated. A
salpingostomy is morally prohibited because it is a direct abortion. The
direct intention of the phys ician is to terminate the embryo. MTX
treatment is morally ambiguous because it is the trophoblast that is directly
affected, not the cytoblast. The direct cause of the pathology - the
trophoblast - is destroyed, and indirectly the cytoblast is separated from
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the wall of the fallopian tubes and dies. To understand this direct/indirect
distinction it is important to first understand how MTX functions.
MTX is a highly toxic folic acid analog which inhibits dehydrofolate
reductase and halts the synthesis of deoxyribonucleic acid (DNA) and cell
multiplication in the trophoblastic tissue.
Studies have shown that
trophoblastic cells are very sensitive to MTX. This toxic drug makes the
trophoblast unable to produce the protein-digesting enzymes necessary for
its penetration into the tissue of the fallopian tube. '6 Prior to giving the
injection of MTX, all patients should have a normal platelet and white
blood cell count, normal liver enzymes, and renal function. After this has
been determined, patients with subnormally rlsmg hCG titers
<2000m1U/ml are given a dose of MTX (SOmglm2) as an intramuscular
injection. Following initial treatment, a hCG titer is obtained on day four
and day seven. The hCG titer in day four will generally be higher than the
hCG titer in day one. If the hCG titer on day seven is less than the hCG
titer on day four the hCG titer is followed weekly unti I negative. If this is
not the case and the hCG is not declining, a second dose of MTX is given
(SO mglm\ and the hCG titers are repeated on days four and seven as with
the first course of treatment. Patients should be informed that the failure
rate for those with an unruptured ectopic pregnancy <3.S cm in greatest
dimension is S%. Also, the majority of patients will have an increase in
17
abdominal-pelvic pain during treatment.
The major function of the MTX treatment is that it interferes with
DNA synthesis and cell multiplication. Since the trophoblastic tissue is
actively proliferating it is very sensitive to the effect of MTX . Ethicist
Albert Moraczewski explains it this way: " Because the trophoblastic cells
are rapidly dividing they are affected more quickly and ful1y than cel1s of
the embryo proper. These are relatively quiescent until an adequate supply
of nourishment is available to them. Once the synthesis of proteolytic
enzymes stops (as a result of MTX), the trophoblastic activity ceases and
further damage is prevented.,, '8 After the trophoblast ceases growth, the
embryo wil1 die and the dead tissue is absorbed into the fallopian tube as
part of the natural healing process. Dr. Eikicki Kojima, of the Tokyo
School of Medicine, explains that, "the process ofthis therapy (intratubal
MTX) is similar to the natural healing process of ectopic pregnancy (such
as would occur in expectant management) because the MTX selectively
suppresses the growth of the trophoblast and induces necrosis; the necrotic
tissue is absorbed in the fallopian tube.', '9 Medical1y, according to a study
done by Dr. Thomas Stovall, of the Bowman School of Medicine at Wake
Forest University, " methotrexate management of the unruptured ectopic
pregnancy <3.5 cm in greatest dimension offers clinical efficiency, minimal
side-effects, minimal lost work time, 9S% success rates, reproductive
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outcomes similar to those obtained with surgery, and a cost profile which
results in considerable savings when compared with surgical
management.,,20 However, ethically , the question which still remains is
whether or not this is a direct or an indirect abortion ? If the effects of
MTX on the trophoblast cannot be viewed as a separate effect from that
which is caused to the cytoblast, it is a direct abortion and morally
unjustifiable. If the effects of MTX on the trophoblast can be separated
from the effects on the cytoblast, it is an indirect abortion and does not
appear to violate the Ethical and Religiolls Directives for Catholic Health
Care. To determine which is true. an ethical analysis of arguments for and
against the use of MTX treatment needs to be examined.

Arguments For and Against Methotrexate
The ethical argument for the use of MTX is directly tied to the 1994
revision of the Ethical and Religious Directives for Catholic Health Care
Services , which no longer teach that certain procedures do not conform to
the moral law. What the directives state is that one can never allow for a
procedure which directly intends the destruction of a viable fetus .
In the case of a tubal pregnancy three medical factors are paramount.
First, the implantation is in an abnormal site, as a result, this is a lifethreatening situation for both the mother and the embryo. Second, this is a
nonviable embryo, because the embryo will never be able to develop and
come to term in its present location. Third, the trophoblast is directly
injuring the tissue of the mother ' s fallopian tube and the result, if not
treated, is threatening to the mother's life. The ethical argument for the use
of MTX focuses on whether one can differentiate between the embryo and
the placenta, or the cytoblast and the trophoblast.
Proponents for the use of MTX in tubal pregnancies argue that it is
ethically justifiable because the direct intention is to inhibit the synthesis of
DNA which will stop the destructive action of the trophoblastic cells.
Arguments in favor of the use of MTX will focus on two main moral
principles: the three-font principle and the principle of double effect.
In the Catholic moral tradition , the three-font principle has been used
to determine the morality of a human action. One must consider three
distinct elements: the intention (the reason the person is performing the
action), the moral object (the precise good freely willed in this act) and the
circumstances (person, place, time, conditions of person s involved, etc.).
For a human action to be morally justified all three elements need to be
morally good . .The intention of the physician in his or her use ofMTX is to
preserve the health and life of the mother and to protect her fallopian tube
for future reproductive activity, not the direct termination of the embryo.
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The tennination of the nonviable embryo is a foreseen but unintended
consequence. The moral object is to stop the destructive nature of the
trophoblast by stopping future protein synthesis. The immediate goal is not
to attack the life of the embryo. Rather, MTX stops the pathological
trophoblastic implanting process that is threatening the mother' s life. As a
result, the trophoblast dies, the cytoblast ' s death follows subsequently, and
21
the mother' s life is no longer directly threatened.
The circumstances are
unlimited in number: the woman ' s age, health, etc . The most relevant
circumstance is that the pregnancy is ectopic, that is, it is in the fallopian
tube which cannot sustain the pregnancy and as a result, the mother' s
health and life are directly threatened and the embryo is nonviable.22 All
three elements of the action appear to be good . The intention is good, that
is to preserve the health and life of the mother. The moral object is good,
that is, MTX will stop the destructive action of the cells in the trophoblast,
which is causing the life-threatening condition to the mother. The moral
object is not a direct attack on the life of the embryo, even though the
foreseen but unintended consequence of the action will be the death of the
nonviable embryo. The circumstances are good, because unless something
is done both the mother and the embryo will die.
Proponents of MTX also argue that it is morally justified by the
principle of double effect. The principle of double effect is a fundamental
principle in Roman Catholic moral theology. As the name implies it refers
to one action with two effects. One effect is intended and morally good;
the other is unintended and morally evil. It is not an inflexible rule or
mathematical fonnula, but rather an efficient guide to prudent moral
23
judgment in solving difficult moral dilemmas.
Historically, many
ethicists believe the premises for the principle can be found in the writings
of Thomas Aquinas in hi s famou s explanation of lawful killing of another
in self-defense in the Summa Theologicae II, q.64,a.7c. However, other
ethicists argue that the four conditions of the principle were not finally
formulated until the mid-nineteenth century by Jean Pierre Gury .24 The
principle of double effect specifies four conditions that must be fulfilled for
an action with both a good and a bad effect to be morally justified.
I) The action , considered by itself and independently of its effects,

must not be morally evil. The object of the action must be good or
indifferent.
2) The evil effect must not be the means of producing the good effect.
3) The evil effect is sincerel y not intended, but merely tolerated .
4) There must be a proportionate reason for performing the action, in
. 0 f t he eVI·1 consequence.-J5
spIte
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The principle of double effect is applicable to the use of MTX for a
tubal pregnancy because it has two I~ffects, one good and the other evil.
The good effect is that the mother' s health is preserved and the evil effect
is that the embryo dies. Proponents argue that MTX is morally justified
because it meets the four conditions of the principle of double effect. The
first condition allows for the injection of MTX because the action in and of
itself is good, in that in stopping the action of the destructive trophoblast
the mother's health and life are preserved. The action does not directly kill
the human embryo. The second condition allows for the injection of MTX
because the good effect is not caused by means of the evil effect. MTX is
an anti-trophoblastic agent, which directly stops further protein synthesis.
MTX achieves its effect by directly impacting on the trophoblast, not the
cytoblast. Therefore, the growth of the trophoblast is stopped without
causing the death of the human embryo. The third condition is met because
the direct intention of the MTX injection is not to kill the embryo, whose
life is as sacred as that of its mother, but to stop the destructive action of
the trophoblast. Finally, there is a proportionate reason for allowing for
MTX because the trophoblast is causing a serious pathological condition,
which is life-threatening to the moth,~r and there is no way to save the life
of the embryo. The foreseen but unintended side effect of the MTX
treatment is the termination of the nonviable cytoblast, which is eventually
absorbed by the mother ' s body. The proportionately grave reason that
allows for the use of MTX is the real and imminent threat of death to the
mother. Moraczewski argues that, "according to available evidence, the
eventual death of the trophoblast is not the means by which further growth
and proteolytic activity is stopped . Rather, the death of the trophoblast
follows eventually from the cessation of cell division .,,26 Therefore, since
the use of MTX meets all four conditions of the principle of double effect,
one would be morally justified in using MTX in the case of a tubal
pregnancy.
Opponents to the use of MTX for tubal pregnancies argue that MTX
is a form of direct abortion. Their argumentation is twofold: first , one
cannot separate the trophoblast from the cytoblast. They are two composite
parts of the human embryo and both are vital to the good of the unborn
child. Ethicist William E. May of the John Paul II Institute for Studies on
Marriage and Family argues that the trophoblast " is a vital organ of the
unborn baby during gestation . Although it is discarded later on , it must be
regarded as an integral part of the body of the unborn child ."n The human
embryo is an innocent person and MTX causes the direct tennination of the
unborn child . May states, " One chooses to use MTX precisely because one
knows that it will destroy the trophoblast. i.e. , a vital organ of the unborn
child. Its 'therapeutic' effect is achieved only by means of its lethal effect
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on the unborn child. Moreover, the ' therapeutic effect' does not benefit the
unborn child but the mother, and does so only because its nontherapeutic
effect destroys the trophoblast of the unborn child, thus causing its
death .,,28 When one attacks the trophoblast one is directly attacking the
unborn child .
Second, MTX is not morally justified by the principle of double
effect. First, the action of administering MTX, considered in and of itself,
is morally evil. MTX directly kills the unborn child. Second, the evil
effect - the death of the unborn child - causes the good effect, the
preservation of the mother' s life. MTX directly impacts on the unborn
child. As a result, the effects of MTX do not benefit the unborn child, who
is killed as a result of its use; instead, it benefits the mother. Third, the evil
effect is directly intended. MTX does not remove damaged tubal tissue as
Moraczewski argues; instead, opponents believe that the direct intention of
using MTX is to remove the unborn child from the fallopian tube. MTX
directly attacks the unborn child for the benefit of the mother. 29 Finally,
there is not a proportionate reason for allowing for MTX because there is a
viable option - a full or partial salpingectomy. The only reason that MTX
is used and justified is because it preserves the fertility of the affected
fallopian tube. 30 The preservation of a woman ' s fertil ity cannot be justified
by the direct death of an unborn child .
May argues that if MTX is morall y justified for tubal pregnancies,
others may view this as a legitimate way to perform direct abortions. It will
open the door to the " slippery slope.',3 1 His claim is supported by Dr.
Bernard Nathanson . In an address Nathanson gave at the National Law
Center of Virginia on January 19, 1998, he stressed that " in coming years
the drive to use chemical means, predominately methotrexate, to perform
abortions will become intense because this will enable ' respectable'
doctors to offer the 'service ' of abortion in their private offices. The use of
MTX to manage tubal pregnancies can only be regarded as a direct abortion
and an attack on the life of the unborn .,,32 MTX treatment sets a dangerous
precedent and the logical consequences that may follow seem inevitable.
Opponents believe that their arguments against the use of MTX for tubal
pregnancies are firmly grounded in the Catholic moral tradition. MTX
directly terminates the life of the unborn child for the benefit of the mother.
" Even if its death is not precisely the means chosen, one cannot exclude
from the means chosen the intentional violation of the bodily integrity of
the unborn child and the causing of its death , and doing so, not for its
benefit, but for the benefit of another. ,,33 Therefore, the on Iy morally
justifiable procedure that can be used with a tubal pregnancy is a partial or
full salpingectomy, because the procedure is performed on the mother, and
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the death of the unborn child is not part of the procedure but a side effect
that one does not directly intend.

Ethical Analysis
I believe that the use of MTX for tubal pregnancies is morally
justified both by the three-font principle and the principle of double effect.
The intention of the physician is to preserve the health and life of the
mother, the object of the action is to stop the destructive enzymatic activity
of the trophoblast, and the circumstances of a tubal pregnancy warrant such
an action. The result is that the mother' s life is preserved. A foreseen
consequence of this action is the death of the embryo but this is not
intended as a means or an end. What is directly intended is to stop the DNA
synthesis so that the life-threatening condition to the mother is avoided.
I also agree with Moraczewski that the use of MTX is morally
justified by the principle of double effect. The intention of using MTX is
not the direct killing of the embryo but the preservation of the mother's
health and life. The embryo ' s death is unintended. The death of the
embryo is not what preserves the health and life of the mother; it is causally
connected with the life-saving action. The evil effect of killing the embryo
is not part of what the physician intends to do when using MTX, but is
brought about in doing what one does..J 4 Tuohey argues that, " It is true that
in moving from the ectopic site to the trophoblast as the object of the
procedure one is moving materially closer to the removal of the embryo
itself as the means to the end of saving the woman 's health and well-being.
However, it is not correct to say thaI: one is moving closer to the embryo.
The conditions of the principle of double effect are not violated . As long
as it is the trophoblast which causes the life-threatening hemorrhage, the
procedure materially touches the trophoblast as its object, and neither the
second nor third conditions are violated .,,35 This leads to the fourth
condition: is there a proportionate reason for permitting the use of MTX? I
would argue that the justification of lVITX by the principle of double effect
rests on whether there is a proportionately grave reason for causing the
unintended death of the embryo.
Proportionate reason refers to both a specific value and its relation to
all the elements (including premoral evils) in the action:16 The specific
value in using MTX is to preserve the health and life of the mother. The
premoral evil, which will inevitably come about by trying to achieve this
value, is the foreseen but unintended death of the human embryo. The
moral question is whether the value of preserving the health and life of the
mother outweighs the premoral evil cfthe foreseen but unintended death of
the nonviable human embryo. To deternline if a proper relation exists
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between the specific value and the other elements of the act, ethicist
Richard McCormick, SJ. , proposes three criteria for the establishment of
proportionate reason :
I) The means used will not cause more harm than necessary to
achieve the value.
2) No less harmful way exists to protect the value.
3) The means used to achieve the value will not undermine it. 37
The application of McConnick 's criteria to the use of MTX for a
tubal pregnancy supports the argument that there is a proportionate reason
for allowing this procedure. First, the use of MTX will cause the least
amount of harm to achieve the value of preserving the mother's health and
life. The va lue of the mother's life and the life of the embryo are equal;
however, there is no chance that the embryo will survive under any
circumstances. MTX will not only save the mother's life but also will
preserve the ferti I ity of her fallopian tube for possible future pregnancies.
Second, there is no less harmful procedure available to protect the value of
the mother's health and life. It is true that a salpingectomy will save the
mother ' s life but it will not prese rve the fertility of her fallopian tube.
MTX treatment is less invasive and less costly and it is the least harmful
procedure for the mother; therefore, it seems to be the best means available
at the present moment. Third, the use of MTX does not undermine the
value of human life. One can argue convincingly that MTX affects the
destructive action of the trophoblastic cells directly, and as a result the
trophoblast and the cytoblast die. In the process, it preserves the value of
human life, because the mother 's life is preserved and the death of the
nonviable embryo is a foreseen but unintended consequence. May ' s
argument that MTX directly attacks the unborn child because the
trophoblast is a vital organ of the unborn child during gestation is incorrect.
The direct attack is on the trophoblastic cells not the unborn child.
A basic rule of Christian ethics based in love is that when confronted
with several possibilities, one ought to do that which will contribute the
most to the well-being and development of persons and their social
relations and to avoid as much as possible those elements that would harm
38
or hinder this well-being. MTX will certainly contribute to the well-being
and development of affected mothers because this procedure will preserve
the fertility of their fallopian tube and therefore allow for the possibility of
future pregnancies and the gift of life . It seems clear that there is a
proportionate reason for allowing MTX treatments for tubal pregnancies,
therefore, it is morally justified under the principle of double effect.
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The ethical dilemma remainin g is that the proponents and opponents
of MTX base their moral arguments o n spec ific interpretations of the
principle of double effect. Bot h si des contend that they have a so lid mora l
argument for their respecti ve pos iti e ns. The re sult is a lack of moral
certitude regarding the leg itimacy of MTX treatment according to the 1994
revision of the Ethical and Religiolls Directives for Catholic Health Care
Services. In moral term s, there is a leg itimate doubt of law. The Catholic
moral tradition has always made prov is io ns for s ituat ions where there are
legitimate doubts of fact about th e ex istence. content or a pplication of a
particular moral obligation o r a do ubt o f law . When there are seriou s
doubts of fact o r law o ne may empl oy the principle of probabilism.
Probabilism states that "if the law less ness of an action is doubtful o ne may
follow a solidly probabl e o pini o n w hich fa vors liberty o f action, even if the
opposite is more probabl e." )?
A so lidly probab le o pinion can be
determined both intrins ically and extrin sica ll y. "Pro babili ty is sa id to be
intrinsic when the reasons for a n opin io n a re cogent but not conclu s ive; it is
called extrinsic when the authority. karning. prudence. of o ther people are
taken as proof that the o pini on in qu esti o n is a probab ly true o pini on. "~o A
do ubt of law pertainin g to MT X treatm ents is quite ev ident. Tuo hey argues
" now that the Bishops no longe r ex plicitly state that th e law applies to
procedures which are a 'separat ion of the e mbryo or fetus from its si te
within the part,' one may form the pm babl e o pini on that some procedures
which do just that are nevert hel es:; lic it when the procedure may be
characterized in such a way as to spec ify the o bject as not being the
remova l of an e mbryo. but th e detach i ng of the tropho blast" '~ I
I be lieve the prin ci ple of probabili sm is applicable in thi s situati o n
and further confirms the moral justification for th e use of MTX to treat a
tubal pregnancy. An intrins ic so lidly pro ba bl e o pini o n ex ists for the use of
MTX because a direct a bo rti on appli es to the direct remova l and killing of
the unbo rn child. Since MTX direc ll y affec ts th e troph ob last and no t the
cytoblast, it is doubtful that the law regarding direct abortions pertains to
protectio n o f the tro phobl astic matter. Furthermore, an extrin sic so lidly
pro babl e o pini o n ex ists because a number of e minent mo ra l theologians.
such as Morczewski and T uohey. have argued convi ncin g ly for the moral
justification of MTX . I be li eve others. suc h as Germain Grisez. Joseph
Boy le an d Patri ck Lee. from the ir respecti ve wr itin gs. would a lso agree to
the use o f MTX , beca use the death e f the human embryo is a foreseen but
unintended res ult of th e MTX trea tme nt.·12 T hese mo ral theologians are
eminent a utho riti es in this field : th e re fore , th ei r o pini o ns regarding MTX as
morally justifi ed serve as a so lidl y-extrin s ic probabl e opllllon ,
notw ithstanding the v iews o f Wi lli al1l E. May. Kev in Fla nne ry. SJ .. etc ..
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who argue that they have also presented solidly probable opinions for their
positions. 43
Conclusion

This paper has prese nted a so lidly probable argument for the use of
MTX treatment in the case of a tubal pregnancy. This argument is based
on the fact that MTX attacks th e destructive activity of the trophoblastic
ce ll s directly, and a fore see n but unintended side effect is that the
trophoblast and the embryo wi ll di e as a result of this treatment. Since the
revised 1994 Ethical and Religious Directives for Catholic Health Services
are ambi guou s on whether they would allow for this medica l procedure,
and since a so lidly probable argum ent, supported both by intrinsic and
extrinsic opinions, upholds thi s proced ure as morally licit, I believe it
would be morally justifiable to advise Judy to use MTX as a licit procedure
for th e management of her tubal pregnancy. Her use of MTX is grounded
in the Catholic moral tradition and is supported not only by the three-font
principle and the principle of double effect . but also by the principle of
probabilism . However, due to the moral ambiguity su rrounding this
medical treatment, dial ogue and debate should co ntinue among medical and
ethical profess ional s until the Ho ly See makes a judgment on this specific
med ical procedure. We cannot stand idl y by and in effect deny our fellow
Chri stians an acceptable med ical proced ure that has a solid moral basis
because we fear it mi ght be abused in the future. Fa ilure to act due to fear
of possible abuse would be far more detrim ental , beca use it would
undermine the very foundati on upon which Cath o lic moral theology is
based.
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